Brought to you by 
Inverness Medical Innovations nets $261.3mm with FOPO
13 Feb 2007
Executive Summary
Inverness Medical Innovations (diagnostics and therapeutics for women's health, cardiovascular conditions, and infectious diseases) has netted $261.3mm through the follow-on public offering of 6.9mm common shares at $39.65 apiece. The company, which had initially planned to sell 5mm shares, intends to use a portion of the proceeds to repay debt.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Medical Devices
-
Pharmaceuticals
- OTC, Consumer
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inverness Medical Innovations nets $261.3mm with FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice